Supplementary Materials and Methods

Western Blot Analyses
Left ventricular tissue samples were homogenized in RIPA buffer supplemented with protease (Complete Protease Inhibitor Cocktail Tablets, Roche) and phosphatase inhibitors (10 mM sodium fluoride and 1 mM sodium orthovanadate). 40 µg proteins were separated using denaturing polyacrylamide gels (SDS-PAGE) and blotted onto nitrocellulose membranes (GE Healthcare). Membranes were blocked in 5% dry milk in TBS-T and incubated with the following primary antibodies at 4°C over night: phospho-STAT3 Tyr705 (#9145), total STAT3 (#4904), phospho-p38 MAPK Thr180/Tyr182 (#4511), total p38 MAPK (#8690), phospho-Akt Ser473 (#4060), total Akt (#4691), phospho-p44/42 MAPK Thr202/Tyr204 (#4370), total p44/42 MAPK (#4695), phospho-p70S6K (#9234), total p70S6K (#2708) (all from Cell Signaling). An antibody against vinculin (Sigma V9131) was used for loading control. Secondary detection was performed using HRP-conjugated antibodies (Cell Signaling) and an enhanced chemiluminescence (ECL) reaction followed by detection of bands using a BIO-RAD ChemiDoc XRS+ imaging system. Intensity of protein bands was quantified by densitometry using ImageJ.
Quantitative real time PCR
Left ventricular tissue samples were homogenized in TRIzol reagent (Invitrogen) and total RNA was isolated according to the manufacturer´s instructions. RNA was subsequently purified using RNeasy spin columns (Qiagen) and reverse transcribed using M-MuLV reverse transcriptase (New England BioLabs) and random hexamer primers. Quantitative real time PCR was performed using the ABsolute QPCR SYBR Green Fluorescein Mix (Thermo Scientific) on the iCycler iQ Real-Time PCR detection system (BIO-RAD). Primers were obtained from BioTeZ (Berlin) with the following sequences: Nppa forward 5´-CATCATGGGCTCCTTCTCCAT-3´, Nppa reverse 5´-TGTACACAGGATTTGGTCCAATATG-3´;
Nppb
Gapdh reverse 5´-CCAGGAAATGAGCTTGACAAAGTT-3´. Samples were analyzed in triplicate and target gene expression was normalized against Gapdh. Relative expression differences between groups were determined using the ΔΔCT method.
Supplementary Discussion
Developmental programming of cardiovascular disease has been proposed to involve the renin angiotensin system (RAS). 2 Sex-specific hypersensitivity towards Ang II mediated increase in blood pressure has been demonstrated in growth restricted rats (Supplementary Reference 1 & 2), whereas little is known about direct effects on the IUGR heart. We have previously shown that adult cHccs +/hearts are specifically sensitive to Ang II, evident as an accelerated and overshooting hypertrophic response detectable at the organ as well as cardiomyocyte level after 2 weeks Ang II infusion. 21 Importantly, this exaggerated growth is transient and partially reversed upon long term (i.e. 4 weeks) Ang II treatment without causing LV dysfunction in cHccs +/females. Given that Ang II impacts on the heart by increasing systemic blood pressure as well as by directly acting on cardiomyocytes (Supplementary Reference 3), our previous study could not differentiate between these two effects. Here we show that pressure overload itself does not induce an exaggerated hypertrophic response in cHccs +/versus control hearts after 2 weeks. These data therefore suggest that overshooting cardiomyocyte hypertrophy in Ang II treated cHccs +/hearts is primarily driven by its direct action on cardiomyocytes but not systemic blood pressure regulation. In regard of such interpretation, cardiomyocyte size was not studied after 2 weeks AAC, so we cannot exclude a transient peak in cell size. Nevertheless, such scenario seems unlikely as it is not reflected by echocardiography measurements of LV wall thickness and mass, two parameters that were clearly increased in cHccs +/hearts compared to controls after 2 weeks Ang II. 21 In summary, our data support the idea that IUGR and fetal programming alter the expression and activity of various RAS components in the heart (Supplementary Reference 4 & 5), thereby inducing hypersensitivity towards Ang II. We have previously shown that adaptive cardiomyocyte hypertrophy in cHccs +/hearts upon Ang II stress is dependent on STAT3 signalling. 21 STAT3 is activated 2 weeks after initiation of Ang II infusion and inhibition of JAK/STAT signalling impairs cardiomyocyte growth and LV function in Ang II stressed cHccs +/females. Here we show that STAT3 activity is not different in cHccs +/hearts compared to controls 4 weeks after pressure overload. These data argue for a direct activation of JAK/STAT3 signalling by Ang II via its respective receptors expressed on cHccs +/cardiomyocytes (Supplementary Reference 6), rather than activation secondary to increased blood pressure. We did not measure STAT3 activation after 2 weeks AAC, however, such that we cannot exclude a transient activation as observed upon Ang II stress. 21 Table S5 : Histological data after 4 weeks left ventricular pressure overload adjusted for independent litters/pregnancies. To account for potential effects on cardiac histology caused by intrauterine or postnatal conditions specific to certain pregnancies or litters, data of mice from the same litter was averaged (as recommended in Dickinson H et al., 2016) . 22 That way the sample size (n) represents litter rather than individual mice. Given that Hccs +/+ sham animals and cHccs +/-ACC animals were all from different litters, data and sample size are the same as in Figure 4 -6, whereas both are different in the other groups, for which two mice per litter were included in the study. The latter results in n=2 for cHccs +/sham litters precluding meaningful statistical analyses with this group, such that data is presented only. CSA = cardiomyocyte cross sectional area. Data are shown as mean ± SEM. *P<0.05 versus Hccs +/+ sham
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